Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aligos Therapeutics (ALGS) Gains from Investment Securities (2020 - 2025)

Aligos Therapeutics filings provide 6 years of Gains from Investment Securities readings, the most recent being $885000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 94.47% to $885000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $16.9 million, a 6.94% decrease, with the full-year FY2025 number at $58382.0, down 90.7% from a year prior.
  • Gains from Investment Securities hit $885000.0 in Q4 2025 for Aligos Therapeutics, down from $1.1 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $16.0 million in Q4 2024 to a low of -$459000.0 in Q4 2021.
  • Median Gains from Investment Securities over the past 5 years was $714843.0 (2023), compared with a mean of $2.7 million.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 108.36% in 2021 and later soared 645.97% in 2024.
  • Aligos Therapeutics' Gains from Investment Securities stood at -$459000.0 in 2021, then soared by 2296.57% to $10.1 million in 2022, then crashed by 78.73% to $2.1 million in 2023, then soared by 645.97% to $16.0 million in 2024, then tumbled by 94.47% to $885000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $885000.0 (Q4 2025), $1.1 million (Q3 2025), and $13125.0 (Q2 2025) per Business Quant data.